Osiris Therapeutics (OSIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 36,901 | 8,785 | -3,749 | -35,754 | -246 |
| Depreciation Amortization | 873 | 688 | 993 | 1,035 | 940 |
| Income taxes - deferred | -25,205 | N/A | N/A | N/A | N/A |
| Accounts receivable | 5,113 | -2,280 | -4,449 | -5,426 | -16,848 |
| Other Working Capital | 6,977 | -5,446 | -3,193 | 3,318 | -22,552 |
| Other Operating Activity | -17,355 | -6,970 | 4,160 | 25,848 | 35,557 |
| Operating Cash Flow | $7,304 | $-5,223 | $-6,238 | $-10,979 | $-3,149 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,217 | 7,351 | 1,352 | 18,819 | 2,182 |
| PPE Investments | -242 | -2,008 | -1,350 | -927 | -1,131 |
| Other Investing Activity | 0 | 0 | 0 | 6,180 | 0 |
| Investing Cash Flow | $5,975 | $5,343 | $2 | $24,072 | $1,051 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -45 |
| Common Stock Issued | 7 | 128 | 27 | 987 | 1,685 |
| Common Stock Repurchased | N/A | N/A | -32 | -206 | N/A |
| Dividend Paid | N/A | N/A | N/A | -6,891 | N/A |
| Other Financing Activity | 0 | 0 | -70 | -47 | 250 |
| Financing Cash Flow | $7 | $128 | $-75 | $-6,157 | $1,890 |
| Beginning Cash Position | 3,081 | 2,833 | 9,144 | 2,208 | 2,416 |
| End Cash Position | 16,367 | 3,081 | 2,833 | 9,144 | 2,208 |
| Net Cash Flow | $13,286 | $248 | $-6,311 | $6,936 | $-208 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,304 | -5,223 | -6,238 | -10,979 | -3,149 |
| Capital Expenditure | -242 | -2,008 | -1,350 | -927 | -1,131 |
| Free Cash Flow | 7,062 | -7,231 | -7,588 | -11,906 | -4,280 |